European Journal of Internal Medicine
Volume 19, Issue 4 , Pages 255-260 , June 2008

Sub-clinical vascular disease in type 2 diabetic subjects: Relationship with chronic complications of diabetes and the presence of cardiovascular disease risk factors

  • Jose Ma Mostaza

      Affiliations

    • Atherosclerosis Unit, Hospital Carlos III, Madrid, Spain
    • Corresponding Author InformationCorresponding author. Atherosclerosis Unit; Hospital Carlos III, Sinesio Delgado, 10, 28029 Madrid, Spain. Tel.: +34 91 453 2670; fax: +34 91 733 66 14.
    • ,
  • Carmen Suarez

      Affiliations

    • Internal Medicine Department, Hospital de la Princesa, Madrid, Spain
    • ,
  • Luis Manzano

      Affiliations

    • Internal Medicine Department, Hospital Ramón y Cajal, Madrid, Spain
    • ,
  • Marc Cairols

      Affiliations

    • Vascular Surgery Department, Hospital Bellvitge, Barcelona, Spain
    • ,
  • Fernando López-Fernández

      Affiliations

    • Internal Medicine Department, Hospital Comarcal de Jarrio, Asturias, Spain
    • ,
  • Isabel Aguilar

      Affiliations

    • Internal Medicine Department, Hospital Clínico Virgen de la Victoria, Málaga, Spain
    • ,
  • Fernando Diz Lois

      Affiliations

    • Internal Medicine Department, Hospital Juan Canalejo, A Coruña, Spain
    • ,
  • Juan L. Sampedro

      Affiliations

    • Internal Medicine Department, Hospital San Agustín, Jaén, Spain
    • ,
  • Herminia Sánchez-Huelva

      Affiliations

    • Internal Medicine Department, Hospital Infanta Elena, Sevilla, Spain
    • ,
  • Miguel A. Sanchez-Zamorano

      Affiliations

    • Medical Department, Bristol Myers-Squibb, Madrid, Spain
    • ,
  • on behalf of the MERITO study group

Received 25 September 2006 ,Revised 30 May 2007 ,Accepted 7 June 2007.

References 

  1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–234
  2. Miettinen H, Lehto S, Salomaa V, Mahonen M, Niemela M, Haffner SM, et al. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care. 1998;21:69–75
  3. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364:685–696
  4. Prevost G, Phan TM, Mounier-Vehier C, Fontaine P. Control of cardiovascular risk factors in patients with type 2 diabetes and hypertension in a French national study (Phenomen). Diabetes Metab. 2005;31:479–485
  5. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004;27:1954–1961
  6. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10–11 February 1998, Miami, Florida. In: Diabetes Care. vol. 21:American Diabetes Association; 1998;p. 1551–1559
  7. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation. 2004;109:733–739
  8. MacGregor AS, Price JF, Hau CM, Lee AJ, Carson MN, Fowkes FG. Role of systolic blood pressure and plasma triglycerides in diabetic peripheral arterial disease. The Edinburgh Artery Study. Diabetes Care. 1999;22:453–458
  9. Al-Delaimy WK, Merchant AT, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men. Am J Med. 2004;116:236–240
  10. Wattanakit K, Folsom AR, Selvin E, Weatherley BD, Pankow JS, Brancati FL, et al. Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 2005;180:389–397
  11. Faglia E, Caravaggi C, Marchetti R, Mingardi R, Morabito A, Piaggesi A, et al. Screening for peripheral arterial disease by means of the ankle-brachial index in newly diagnosed Type 2 diabetic patients. Diabet Med. 2005;22:1310–1314
  12. Lange S, Diehm C, Darius H, Haberl R, Allenberg JR, Pittrow D, et al. High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes. Exp Clin Endocrinol Diabetes. 2004;112:566–573
  13. O'Hare AM, Rodriguez RA, Bacchetti P. Low ankle-brachial index associated with rise in creatinine level over time: results from the atherosclerosis risk in communities study. Arch Intern Med. 2005;165:1481–1485
  14. Migdalis IN, Dimakopoulos N, Kourti A, Tolis A, Koutoulidis K, Samartzis M. The prevalence of peripheral vascular disease in type 2 diabetic patients with and without proteinuria. Int Angiol. 1994;13:229–232
  15. American Diabetes Association: clinical practice recommendations. Diabetes Care. 2002;25 Suppl 1:S1–1472002
  16. Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2002;285:2486–2497
  17. Murabito JM, Evans JC, Nieto K, Larson MG, Levy D, Wilson PW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002;143:961–965
  18. Curb JD, Masaki K, Rodriguez BL, Abbott RD, Burchfiel CM, Chen R, et al. Peripheral artery disease and cardiovascular risk factors in the elderly. The Honolulu Heart Program. Arterioscler Thromb Vasc Biol. 1996;16:1495–1500
  19. Lahoz C, Vicente I, Laguna F, Garcia-Iglesias MF, Taboada M, Mostaza JM. Metabolic syndrome and asymptomatic peripheral artery disease in subjects over 60 years of age. Diabetes Care. 2006;29:148–150
  20. Kallio M, Forsblom C, Groop PH, Groop L, Lepantalo M. Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years. Diabetes Care. 2003;26:1241–1245
  21. Wannamethee SG, Shaper AG, Lennon L. Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease. Heart. 2004;90:1398–1403
  22. O'Hare AM, Glidden DV, Fox CS, Hsu CY. High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999–2000. Circulation. 2004;109:320–323
  23. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation. 2004;110:738–743
  24. O'Hare AM, Vittinghoff E, Hsia J, Shlipak MG. Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen/Progestin Replacement Study (HERS). J Am Soc Nephrol. 2004;15:1046–1051
  25. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26:3333–3341
  26. Alexandrova NA, Gibson WC, Norris JW, Maggisano R. Carotid artery stenosis in peripheral vascular disease. J Vasc Surg. 1996;23:645–649
  27. Cina CS, Safar HA, Maggisano R, Bailey R, Clase CM. Prevalence and progression of internal carotid artery stenosis in patients with peripheral arterial occlusive disease. J Vasc Surg. 2002;36:75–82
  28. Di Carli MF, Hachamovitch R. Should we screen for occult coronary artery disease among asymptomatic patients with diabetes?. J Am Coll Cardiol. 2005;45:50–53

PII: S0953-6205(07)00381-0

doi: 10.1016/j.ejim.2007.06.018

European Journal of Internal Medicine
Volume 19, Issue 4 , Pages 255-260 , June 2008

Article Tools